Sample: Maternal blood
Results: 7–12 days
A combined maternal carrier and prenatal chromosome screen with added fetal-antigen information. The catalogue describes carrier screening with conditional single-gene NIPT follow-up alongside chromosome and fetal-antigen assessments. These are screening results, not a diagnosis. BabyPeek is available free of charge as an add-on to UNITY packages.
• Maternal carrier screening for selected inherited conditions, including cystic fibrosis and spinal muscular atrophy
• Single-gene NIPT reflex assessment if indicated by the carrier screen
• Screening for trisomies 13, 18 and 21 and sex chromosome differences
• Fetal sex and RhD status screening
• Selected fetal red blood cell antigen screening; confirm the exact antigen list with the clinic
• 22q11.2 deletion syndrome screening
It combines carrier screening, trisomies 13, 18 and 21, sex chromosome screening, fetal RhD and selected blood-antigen information, plus 22q11.2 screening.
The catalogue names cystic fibrosis and spinal muscular atrophy among the inherited conditions.
The package lists a maternal blood sample.
Results are available in 7–12 days, with a maximum turnaround of 12 days.
No. Screening findings should be reviewed with a clinician, who can advise on confirmatory testing.
